新药临床试验中受试者集体交涉权的伦理辩护  

On the Collective Bargaining Right of the Human Subject in the New Drug Clinical Trial and Its Ethical Justification

作　　者：王芳芳[1,2] 

机构地区：[1]中国人民大学哲学院,北京100872 [2]爱知大学国际中国学研究中心

出　　处：《昆明理工大学学报（社会科学版）》2015年第1期1-7,共7页Journal of Kunming University of Science and Technology(Social Sciences)

基　　金：教育部哲学社会科学研究后期资助项目"现代化视镜下中国公民道德探析"(11JHQ043)

摘　　要：受试者集体交涉权的产生是传统医学模式发展至现代新医学模式的一个必然结果。基于社会资本立场,受试者集体交涉权的产生也是公民参与理性发展的结果。受试者保护问题的提出深刻反映了医学模式转变、生命伦理规范革新等医学伦理方面的新进展,要求加强建构主义意义上的制度建设,为社会弱势群体提供利益表达渠道和诉求机制。组建受试者自我组织是落实受试者权益保护的重要途径,它将在信息披露、沟通协调等方面发挥重要功能。网络环境下的发展机制及协调与相关政府部门的关系是受试者自我组织当前发展面临的难题。The human subjects' collective bargaining power is an inevitable result of the development of the traditional medical model to the new modern medical model.Based on the social capital position,it is also the result of rational development of citizen participation.The protection of the subjects reflects the new progress of medical ethics,such as the profound changes in the medical model,and new innovations in bioethics specification,and in constructivist sense,which requires institutional strengthening in order to provide channels for the expression of the interests of vulnerable groups in society.The formation of subjects' self-organization is an important way to protect the interests of the subjects,and it will play an important role in information disclosure,communication and coordination and the like.The mechanism of development under the network environment and the coordination with relevant government departments are the current challenges facing the development of the subjects' self-organization.

关 键 词：新药临床试验 受试者 社会资本 集体交涉权 受试者自我组织 

分 类 号：B82-05[哲学宗教—伦理学]